Importing drugs from Canada may increase the risk of US citizens being exposed to unsafe medicines.
Paul W. Abramowitz
Advertisement
Paul W. Abramowitz, PharmD, ScD (Hon), FASHP, is the CEO of the American Society of Health-System Pharmacists.
Articles by Paul W. Abramowitz
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5